The Ocean Molecule That Made Cancer Cells Explode
A discovery from the deep is rewriting what we thought cancer treatment could look like and what the ocean might still be hiding.
A discovery from the deep is rewriting what we thought cancer treatment could look like, and what the ocean might still be hiding.
It doesn’t look like a breakthrough.
It looks like slime.
Somewhere off the coast of Taiwan, a microbe was secreting a sticky sugar substance, the way some marine bacteria do to protect themselves in saltwater or cling to surfaces. No one knew what this slime could do.
Then scientists put it in a Petri dish with immune cells commonly used to study cancer biology.
What happened next wasn’t just healing, it was a demolition.
A New Way to Kill Cancer Cells
We already know that cells can die quietly. They can wither, shut down, and be absorbed without fuss in a process called apoptosis. There’s another kind of cell death that’s loud, messy and violent. It’s called pyroptosis, from the Greek word pyro, meaning fire.
Pyroptosis is the cellular equivalent of pulling a fire alarm in a building wired with explosives.
In a peer-reviewed study, released last week, researchers found that a molecule secreted by marine bacteria, dubbed EPS3.9, triggers this exact response. First, the molecule latches onto the outside of a cancer cell. That contact sets off an internal sensor system, the NLRP3 inflammasome. Like a tripwire, it activates an enzyme (caspase-1), which slices open another protein, gasdermin-D. The sliced protein drills holes in the cell’s outer membrane.
Water rushes in. The cell swells. Then it bursts.
What’s left is a flood of chemical distress signals that alert the immune system and trigger a wave of inflammation.
To picture it more clearly…
Imagine a balloon filled with water and alarms. EPS3.9 lands on the surface like a spark. That spark pulls the fire alarm. The alarm calls in a demolition crew, which punches holes in the balloon. It bursts, releasing a chemical flare into the sky that screams, “Danger here”.
From a cancer research perspective, this is a dream outcome. A cell that doesn’t just die, it dies screaming for help.
From Slime to Shrinking Tumours
So far, EPS3.9 has only been tested in preclinical settings. In Petri dishes, it triggered pyroptosis in THP-1 cells, a human-derived immune cell line commonly used to study inflammation and cancer biology.
To go a step further, the researchers implanted human liver cancer cells into specially bred mice with weakened immune systems, a method widely used in cancer research, though not without ethical concerns. When the mice were treated with EPS3.9, their tumours shrank and signs of inflammation increased.
There were limitations. The study didn’t track how long the mice lived. It didn’t compare EPS3.9 to existing cancer drugs. This wasn’t a cure. It was an early signal, but a powerful one.
Why This Molecule Matters
EPS3.9 is what scientists call an extracellular polymeric substance, a sugar-based matrix secreted by bacteria. These compounds aren’t new. What makes EPS3.9 stand out is its shape and structure. It’s large (around 171 kilodaltons), sticky, and built from a distinctive blend of sugars, including mannose and glucose. That sticky surface may help it bind more effectively to cancer cells and trip their internal alarm systems.
Other marine microbes, like Pseudoalteromonas and Vibrio species, have produced anticancer compounds. Some induce apoptosis. Some show promise in lab studies. EPS3.9 is different. It was shown to directly trigger pyroptosis, and reduce tumour size in a living organism.
What Happens Next?
This is early-stage research. EPS3.9 has not been tested in humans. We don’t know how easily it can be produced at scale, how safe it is over time, or how it might behave inside a fully functioning immune system.
Clinical trials, if they happen, are years away.
Still, this discovery shines light on something bigger.
Most current cancer treatments rely on passive, quiet cell death. EPS3.9 offers the opposite, a biological signal that may help amplify the body’s natural immune response.
That kind of strategy, turning the tumour into its own flare, is one of the most promising frontiers in cancer immunotherapy.
The Ocean Has Always Held the Answers
We have mapped more of Mars than the seafloor. Yet the ocean keeps revealing secrets.
This discovery didn’t come from a lab synthesiser or a supercomputer. It came from Bacillus sp. 3.9, a microbe found off the coast of Taiwan. Left alone in the dark, it evolved to produce a slime that now shows potential as a new class of cancer treatment.
This is why marine ecosystems matter. Every reef, bay and estuary we lose might be hiding the next EPS3.9. The next antibiotic. The next clue to healing ourselves.
We often talk about the ocean as a source of food, carbon storage, or biodiversity. It is all of those things. It is also a pharmacy we barely understand.
If slime from one marine microbe can burst cancer cells wide open, what else is out there waiting to be found?
Please consider liking, restacking or sharing if this piece struck a chord. It helps raise the alarm and fuels this kind of independent ocean journalism that challenges, informs, and (hopefully) makes a difference.
If you haven’t already, I’d love it if you subscribed. You’ll receive articles and the Voice for the Blue podcast straight into your inbox every few days.
This kind of blew (blue) my mind!!
Infectious diseases, one of the big climate healthcare challenges will be compounded massively by antimicrobial resistance. I cannot remember the exact number but there's approximately 30 drugs currently on the market which have been derived from Ocean species. The genes coding for molecules which are used as chemical defence (many benthic species do not move fast or at all) could hold the code for new antimicrobial classes which we are lacking at present. Most of the marine-derived drugs on the market today are however cancer-focussed which I believe is where the profit lies. There are minimal financial incentives to develop antimicrobials although I believe there is work in progress to address.